US IPO Week Ahead: Life Sciences

Silk Road Medical (SILK) could see a lot of interest, based on its fast growth (+142% in 2018 on $35mm of sales) and the returns of recent IPO device maker ShockWave Medical (SWAV; +100% from IPO).

NGM Biopharmaceuticals (NGM) is the latest billion-dollar biotech, attempting tor raise $100 million at a valuation of $1.1 billion. Like this past week’s Genfit (GNFT), NGM is targeting NASH, among other diseases.

https://www.renaissancecapital.com/IPO-Center/News/62431/US-IPO-Week-Ahead-Tradeweb-is-the-hot-trade-in-a-4-IPO-week